The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0157-2027·Announced 2026-11-11

AvKARE Recalls Fludrocortisone Acetate Tablets Due to Impurity Failures

AvKARE is recalling 8,866 cartons of Fludrocortisone Acetate Tablets, USP 0.1mg, because the product failed impurities and degradation specifications.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II due to failed impurities and degradation specifications. The source does not report any illnesses, injuries, or deaths.

Plain-English summary

AvKARE is recalling 8,866 cartons of Fludrocortisone Acetate Tablets, USP 0.1mg, NDC 50268-330-15. The recall was initiated because the product failed impurities and degradation specifications.

The affected product is Lot # 48353 with an expiration date of 10/31/2026. The tablets are packaged in 50-tablet unit dose AVPAKs and were distributed nationwide in the United States.

Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or healthcare provider for a replacement or further instructions.

The recalled product

Product
FLUDROCORTISONE ACETATE (FLUDROCORTISONE ACETATE)
Brand
FLUDROCORTISONE ACETATE
Manufacturer
AvKARE
Affected units
8,866

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 48353
  • Exp. 10/31/2026

Distribution

Distributed nationwide across the United States.

Similar recalls